Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1726 |
TAM
Thornmark Asset Management
Toronto,
Ontario, Canada
| $0 | -$572K | 0 | – | Closed |
|
| 1727 |
TT
Tiedemann Trust
Wilmington,
Delaware
| $0 | -$424K | 0 | – | Closed |
|
| 1728 |
TLCM
Tiger Legatus Capital Management
New York
| $0 | -$2.66M | 0 | – | Closed |
|
| 1729 |
TP
Traxis Partners
Greenwich,
Connecticut
| $0 | -$10.9M | 0 | – | Closed |
|
| 1730 |
TSBJ
Trevor, Stewart, Burton & Jacobsen
New York
| $0 | -$902K | 0 | – | Closed |
|
| 1731 |
TSWM
Triangle Securities Wealth Management
Raleigh,
North Carolina
| $0 | -$50K | 0 | – | Closed |
|
| 1732 |
TCM
Twin Capital Management
Mcmurray,
Pennsylvania
| $0 | -$784K | 0 | – | Closed |
|
| 1733 |
VFAM
Valley Forge Asset Management
King Of Prussia,
Pennsylvania
| $0 | -$362K | 0 | – | Closed |
|
| 1734 |
VF
Virtu Financial
New York
| $0 | -$3.12M | 0 | – | Closed |
|
| 1735 |
VBCP
Vollero Beach Capital Partners
New York
| $0 | -$13.4M | 0 | – | Closed |
|